These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15516756)

  • 61. MF-8, a novel promising arylpiperazine-hydantoin based 5-HT
    Latacz G; Lubelska A; Jastrzębska-Więsek M; Partyka A; Kucwaj-Brysz K; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Bioorg Med Chem Lett; 2018 Mar; 28(5):878-883. PubMed ID: 29439902
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Discovery of benzhydrylpiperazine derivatives as CB1 receptor inverse agonists via privileged structure-based approach.
    Meng T; Wang J; Peng H; Fang G; Li M; Xiong B; Xie X; Zhang Y; Wang X; Shen J
    Eur J Med Chem; 2010 Mar; 45(3):1133-9. PubMed ID: 20047779
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Zwitterionic CRTh2 antagonists.
    Luker T; Bonnert R; Paine SW; Schmidt J; Sargent C; Cook AR; Cook A; Gardiner P; Hill S; Weyman-Jones C; Patel A; Thom S; Thorne P
    J Med Chem; 2011 Mar; 54(6):1779-88. PubMed ID: 21355602
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Design, synthesis, and alpha(1)-adrenoceptor binding properties of new arylpiperazine derivatives bearing a flavone nucleus as the terminal heterocyclic molecular portion.
    Betti L; Floridi M; Giannaccini G; Manetti F; Paparelli C; Strappaghetti G; Botta M
    Bioorg Med Chem; 2004 Mar; 12(6):1527-35. PubMed ID: 15018926
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.
    Andrieu T; Bertolini R; Nichols SE; Setoud R; Frey FJ; Baker ME; Frey BM
    Biochem Pharmacol; 2011 Dec; 82(11):1651-62. PubMed ID: 21907706
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Small molecule biaryl FSH receptor agonists. Part 2: Lead optimization via parallel synthesis.
    Guo T; Adang AE; Dong G; Fitzpatrick D; Geng P; Ho KK; Jibilian CH; Kultgen SG; Liu R; McDonald E; Saionz KW; Valenzano KJ; van Straten NC; Xie D; Webb ML
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1717-20. PubMed ID: 15026057
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Novel androgen receptor full antagonists: Design, synthesis, and a docking study of glycerol and aminoglycerol derivatives that contain p-carborane cages.
    Kaise A; Ohta K; Fujii S; Oda A; Goto T; Endo Y
    Bioorg Med Chem; 2018 Jul; 26(13):3805-3811. PubMed ID: 29903411
    [TBL] [Abstract][Full Text] [Related]  

  • 68. De novo design of a picomolar nonbasic 5-HT(1B) receptor antagonist.
    Nugiel DA; Krumrine JR; Hill DC; Damewood JR; Bernstein PR; Sobotka-Briner CD; Liu J; Zacco A; Pierson ME
    J Med Chem; 2010 Feb; 53(4):1876-80. PubMed ID: 20088516
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Design and synthesis of novel androgen receptor antagonists via molecular modeling.
    Zhao C; Choi YH; Khadka DB; Jin Y; Lee KY; Cho WJ
    Bioorg Med Chem; 2016 Feb; 24(4):789-801. PubMed ID: 26780832
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel 17 substituted pregnadiene derivatives as 5 alpha-reductase inhibitors and their binding affinity for the androgen receptor.
    Cabeza M; Flores E; Heuze I; Sánchez M; Bratoeff E; Ramírez E; Francolugo VA
    Chem Pharm Bull (Tokyo); 2004 May; 52(5):535-9. PubMed ID: 15133203
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synthesis and in vitro pharmacological evaluation of novel 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands.
    Fiorino F; Magli E; Severino B; Corvino A; Ciano A; Perissutti E; Frecentese F; Massarelli P; Nencini C; Santagada V; Caliendo G
    Arch Pharm (Weinheim); 2014 Oct; 347(10):698-706. PubMed ID: 25113046
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 3. Replacement of quinazoline moiety and improvement of metabolic polymorphism of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.
    Matsuno K; Ushiki J; Seishi T; Ichimura M; Giese NA; Yu JC; Takahashi S; Oda S; Nomoto Y
    J Med Chem; 2003 Nov; 46(23):4910-25. PubMed ID: 14584942
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Design and synthesis of 4-benzyl-1-(2H)-phthalazinone derivatives as novel androgen receptor antagonists.
    Inoue K; Urushibara K; Kanai M; Yura K; Fujii S; Ishigami-Yuasa M; Hashimoto Y; Mori S; Kawachi E; Matsumura M; Hirano T; Kagechika H; Tanatani A
    Eur J Med Chem; 2015 Sep; 102():310-9. PubMed ID: 26295173
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthesis and anticancer evaluation of 2-oxo-2-(arylamino) ethyl 4-phenylpiperazine-1-carbodithioates.
    Hafeez F; Zahoor AF; Rasul A; Ahmad S; Mansha A
    Pak J Pharm Sci; 2021 Jan; 34(1(Supplementary)):353-357. PubMed ID: 34275861
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis, bioactivity, and molecular docking of novel arylpiperazine derivatives as potential AR antagonists.
    Qi Y; Chen H; Chen S; Shen J; Li J
    Front Chem; 2022; 10():947065. PubMed ID: 36046733
    [TBL] [Abstract][Full Text] [Related]  

  • 76. N-dealkylation of arylpiperazine derivatives: disposition and metabolism of the 1-aryl-piperazines formed.
    Caccia S
    Curr Drug Metab; 2007 Aug; 8(6):612-22. PubMed ID: 17691920
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Development of
    Yamada A; Kazui Y; Yoshioka H; Tanatani A; Mori S; Kagechika H; Fujii S
    ACS Med Chem Lett; 2016 Dec; 7(12):1028-1033. PubMed ID: 27994732
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synthesis and diversity analysis of lead discovery piperazine-2-carboxamide libraries.
    Herpin TF; Morton GC; Dunn AK; Fillon C; Menard PR; Tang SY; Salvino JM; Labaudinière RF
    Mol Divers; 1998; 4(4):221-32. PubMed ID: 10849899
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Facile green approach towards the synthesis of some phenyl piperazine based dithiocarbamates as potent hemolytic and thrombolytic agents.
    Hafeez F; Mansha A; Fawad Zahoor A; Ghulam Ali K; Gul Khan S; Raza Naqvi SA
    Pak J Pharm Sci; 2021 Sep; 34(5(Supplementary)):1885-1890. PubMed ID: 34836855
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mass ligand binding screening for receptor antagonists: prototype new drugs and blind alleys.
    Burch RM
    J Recept Res; 1991; 11(1-4):101-13. PubMed ID: 1653329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.